Improving Followup of Positive Fecal Occult Blood Tests
Screening programs using the fecal occult blood test (FOBT) have demonstrated a significant
reduction in colorectal cancer mortality, although only when accompanied by a complete
diagnostic evaluation of the colon in the setting of a positive result. 90% of patients
with a positive FOBT result have completed a subsequent colonoscopy within Harvard Vanguard
Medical Associates. This project will use a pre-post study design to increase the rate of
followup colonoscopy in the setting of positive FOBT results. Patients in the intervention
group will receive a personalized mailing highlighting their positive result and need for
colonoscopy, followed by telephone outreach from a centralized gastroenterology scheduling
office. The primary outcome will be the performance of colonoscopy, however we will also
perform chart reviews to identify predictors of completing appropriate followup.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Performance of colonoscopy
6 months
Thomas D Sequist, MD, MPH
Principal Investigator
Harvard Vanguard Medical Associates
United States: Institutional Review Board
Sequist Colorectal Cancer
NCT00436137
June 2007
March 2008
Name | Location |
---|---|
Harvard Vanguard Medical Associates | Newton, Massachusetts 02466 |